Davis, Rebecca <br/><br/>
Comparative effectiveness of antitumour necrosis factor agents and vedolizumab in ulcerative colitis.  [electronic resource] 

 -  European journal of gastroenterology & hepatology  Jun 2019 
 - 661-667 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1473-5687 
<br/><br/><label>Standard No.: </label>10.1097/MEG.0000000000001395  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--therapeutic use<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Colitis, Ulcerative--drug therapy<br/>Comparative Effectiveness Research<br/>Female<br/>Gastrointestinal Agents--therapeutic use<br/>Glucocorticoids--therapeutic use<br/>Humans<br/>Infliximab--therapeutic use<br/>Maintenance Chemotherapy<br/>Male<br/>Middle Aged<br/>Remission Induction<br/>Retrospective Studies<br/>Treatment Outcome<br/>Tumor Necrosis Factor Inhibitors--therapeutic use